基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抑制剂 蛋白酪氨酸激酶 N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺 Foretinib
  • Foretinib

Foretinib

Foretinib
其他 更新日期:2012-05-28

Biotool LLC

非会员
联系人:Marketing
电话:+1-832-582-8158拨打
邮箱:marketing@biotool.com

产品详情:

中文名称:
Foretinib
英文名称:
Foretinib
CAS号:
849217-64-7

Foretinib (GSK1363089, XL880) is a novel MET and VEGFR2/KDR kinases inhibitor with an IC50 of 0.4 and 0.8 nM for MET and KDR, respectively. Foretinib (GSK1363089, XL880) inhibits HGF receptor family tyrosine kinases with an IC50 of 3 nM for Ron. Foretinib (GSK1363089, XL880) also inhibits KDR, Flt-1, and Flt-4 with IC50 of 0.9, 6.8 and 2.8 nM, respectively. In addition, EXEL-2880 inhibits members of the platelet-derived growth factor receptor family and the angiopoietin-1 receptor Tie-2. Foretinib (GSK1363089, XL880) exhibits modest activity against fibroblast growth factor receptor 1 and epidermal growth factor receptor and is inactive against 50 serine/threonine kinases, including cyclin-dependent kinases and protein kinase C isoforms. To delineate the cellular effect of foretinib (GSK1363089, XL880), VEGF- induced extracellular signal-regulated kinase phosphorylation was used to assess the effect of the compound on phosphorylation of KDR in human umbilical vein endothelial cells that resulted in an IC50 of 16 nM. Foretinib(GSK1363089, XL880) is the 1st orally available small molecule inhibitor of Met to enter the clinic and appears to be generally well tolerated. Anti-tumor activity has been observed and Foretinib may represent an active treatment option for patients with papillary renal-cell carcinoma.

c-Met Inhibitors;Foretinib

成立日期
注册资本
员工人数
年营业额
经营模式
主营行业

Foretinib相关厂家报价

  • Foretinib
  • Foretinib
  • 陕西缔都新材料有限公司 VIP
  • 2024-04-23
  • 询价
  • Foretinib
  • Foretinib
  • 上海蓝木化工有限公司
  • 2012-05-28
  • 询价
内容声明
拨打电话 立即询价